Evidence map›Paper›PMID 37332365›Full record

ArticleCritical care explorations2023

Preferred Language Mediates Association Between Race, Ethnicity, and Delayed Presentation in Critically Ill Patients With COVID-19.

Michael S Kelly, Adna Mohammed, Daniel Okin, George A Alba, Sirus J Jesudasen, Shelby Flanagan, Nupur A Dandawate, Alexander Gavralidis, Leslie L Chang, Emily E Moin and 8 more

Open access · goldAbstract read
In one paragraph

Article in Critical care explorations, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Michael S KellyDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Adna MohammedDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Daniel OkinDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
George A AlbaDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Sirus J JesudasenDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Shelby FlanaganDivision of General Pediatrics, Boston Children's Hospital, Boston, MA.
Nupur A DandawateDivision of Pulmonary, Critical Care and Sleep Medicine, Salem Hospital, Salem, MA.
Alexander GavralidisDivision of Pulmonary, Critical Care and Sleep Medicine, Salem Hospital, Salem, MA.
Leslie L ChangDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Emily E MoinDivision of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Alison S WitkinDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Kathryn A HibbertDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Aran KadarDivision of Pulmonary Medicine and Critical Care, Newton-Wellesley Hospital, Newton, MA.
Patrick L GordanDivision of Pulmonary, Critical Care and Sleep Medicine, Salem Hospital, Salem, MA.
Lisa M BebellDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Marissa HauptmanDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Linda ValeriDepartment of Biostatistics, Columbia University Mailman School of Public Health, New York, NY.
Peggy S LaiDepartment of Medicine, Massachusetts General Hospital, Boston, MA.
Massachusetts General Hospital · USHarvard University · USSalem Hospital · USBoston Children's Hospital · USColumbia University · USNewton Wellesley Hospital · USUniversity of Pennsylvania · US

Funding

The school microbiome and asthma morbidity in inner-city childrenR01AI144119 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LAI, PEGGY SUE · 2019 to 2023
$3.7M
MGH Next Generation Physician-Scientist Through Stimulating Access to Research in Residency Program (MGH-Next Gen StARR)R38HL150212 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2020 to 2023
$1.3M
NHLBI NIH HHS R38 HL150212NIAID NIH HHS R01 AI144119
6 · The paper itself

Abstract

Which social factors explain racial and ethnic disparities in COVID-19 access to care and outcomes remain unclear.

objectivesWe hypothesized that preferred language mediates the association between race, ethnicity and delays to care. DESIGN SETTING AND

participantsMulticenter, retrospective cohort study of adults with COVID-19 consecutively admitted to the ICU in three Massachusetts hospitals in 2020. MAIN OUTCOME AND MEASURES: Causal mediation analysis was performed to evaluate potential mediators including preferred language, insurance status, and neighborhood characteristics.

resultsNon-Hispanic White (NHW) patients (157/442, 36%) were more likely to speak English as their preferred language (78% vs. 13%), were less likely to be un- or under-insured (1% vs. 28%), lived in neighborhoods with lower social vulnerability index (SVI) than patients from racial and ethnic minority groups (SVI percentile 59 [28] vs. 74 [21]) but had more comorbidities (Charlson comorbidity index 4.6 [2.5] vs. 3.0 [2.5]), and were older (70 [13.2] vs. 58 [15.1] years). From symptom onset, NHW patients were admitted 1.67 [0.71-2.63] days earlier than patients from racial and ethnic minority groups ( CONCLUSIONS AND RELEVANCE: Preferred language mediates the association between race, ethnicity and delays to presentation for critically ill patients with COVID-19, although our results are limited by possible collider stratification bias. Effective COVID-19 treatments require early diagnosis, and delays are associated with increased mortality. Further research on the role preferred language plays in racial and ethnic disparities may identify effective solutions for equitable care.

Indexed as

casual inferenceCOVID-19critical caredisparitiesmediation analysis

Identifiers

PMID37332365
PMCPMC10270487
OpenAlexW4380627472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.